SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Schedule of Net Sales and Profit, by Segment

Net sales and profit by reportable segment for the years ended December 31, 2022, 2021 and 2020 are as follows:

	Years Ended December 31,
Dollars in thousands	2022		2021		2020
Segment Net Sales
Codman Specialty Surgical	$	1,019,564	$	1,025,232	$	894,831
Tissue Technologies	538,102		517,216		477,037
Total revenues	$	1,557,666	$	1,542,448	$	1,371,868
Segment Profit
Codman Specialty Surgical	$	417,873	$	439,471	$	356,657
Tissue Technologies	233,802		228,199		159,630
Segment profit	651,675		667,670		516,287
Amortization	(13,882)		(16,914)		(27,757)
Corporate and other	(398,873)		(453,526)		(337,160)
Operating income	$	238,920	$	197,230	$	151,370

Schedule of Geographic Revenue, by Area

Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:

Dollars in thousands	United States(1)		Europe		Asia Pacific		Rest of the World		Consolidated
Total revenue, net:
2022	$	1,126,810	$	170,903	$	176,477	$	83,476	$	1,557,666
2021	1,089,526		191,327		182,034		79,561		1,542,448
2020	971,975		172,689		157,174		70,030		1,371,868
Total long-lived assets:
2022	$	440,223	$	60,857	$	12,975	$	2,721	$	516,776
2021	339,535		55,026		11,289		6,836		412,686